19 results
8-K
EX-2.4
LSTA
Lisata Therapeutics Inc
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.2
LSTA
Lisata Therapeutics Inc
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.1
LSTA
Lisata Therapeutics Inc
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.3
LSTA
Lisata Therapeutics Inc
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
DEFA14A
EX-2.1
LSTA
Lisata Therapeutics Inc
17 Mar 17
Additional proxy soliciting materials
12:00am
8-K
EX-2.1
8oizswh2687j0q35o5c
17 Mar 17
Support Agreement and Irrevocable Proxy
12:00am
DEFA14A
EX-2.1
wkrjcw
17 Mar 17
Additional proxy soliciting materials
12:00am
8-K
EX-2.1
rglkfpzlh7291g8y8ad
17 Mar 17
Support Agreement and Irrevocable Proxy
12:00am
8-K
EX-2.1
22yo7scx izf
14 Apr 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
w3bxhipdyjde4 pdr02
24 Aug 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
9tvxvsqigv
18 Jun 12
NeoStem Signs a Definitive Agreement to Divest Its 51% Ownership Interest in Suzhou Erye
12:00am
DEFA14A
EX-2.1
q9e16vbjwz11cl9u1pat
18 Jun 12
Additional proxy soliciting materials
12:00am
425
EX-2.1
a2pykwu49 cwc
14 Jul 11
Business combination disclosure
12:00am
8-K
EX-2.1
aevgu bdjm7zc
14 Jul 11
Entry into a Material Definitive Agreement
12:00am
425
EX-2.1
w6ecf jxizyxs
23 Sep 10
Business combination disclosure
12:00am
8-K
EX-2.1
9wgrmsh5
23 Sep 10
NeoStem and Progenitor Cell Therapy Announce Entry Into Merger Agreement
12:00am
8-K
EX-2.1
zesmarxbpsvdcz6
6 Nov 08
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
0c74dkqc4xom477agh3
6 Nov 08
NeoStem Signs Definitive Agreement to Acquire Controlling Interest in a Leading Chinese Pharmaceutical Company
12:00am
- Prev
- 1
- Next